Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction. (Record no. 17033359)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01970 a2200541 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515065650.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200707s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0008-4212 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1139/y07-006 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Gandhi, Purvi S |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20070720 |
245 00 - TITLE STATEMENT | |
Title | Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Canadian journal of physiology and pharmacology |
Date of publication, distribution, etc. | Feb 2007 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 193-9 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adrenergic beta-Antagonists |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Angiotensin-Converting Enzyme Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carbazoles |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carvedilol |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Myocardial Ischemia |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oxidative Stress |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Propanolamines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stroke Volume |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Systole |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ventricular Dysfunction, Left |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ventricular Remodeling |
General subdivision | drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Goyal, Ramesh K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jain, Anil R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mallya, B Srinivas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gupta, Vishal M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shah, Dhiren S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Trivedi, Bharat R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shastri, Naman A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mehta, Chirag B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jain, Kalpana A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bhavasar, Niren S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shah, Urmi J |
773 0# - HOST ITEM ENTRY | |
Title | Canadian journal of physiology and pharmacology |
Related parts | vol. 85 |
-- | no. 2 |
-- | p. 193-9 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1139/y07-006">https://doi.org/10.1139/y07-006</a> |
Public note | Available from publisher's website |
No items available.